China's Sinovac May Start Philippine Vaccine Trials This Year

Russia Approves 2nd Coronavirus Vaccine – Putin

Russia Approves 2nd Coronavirus Vaccine – Putin

China has been inoculating essential workers with COVID-19 vaccine candidates under an emergency use programme launched in July.

The announcement of the company distributing vaccines to students appeared on a website where people could sign up to receive it, the newspaper reported.

With a second wave of coronavirus cases sweeping Russian Federation, the Kremlin needs the vaccine as it battles rising daily infection rates while seeking to avoid a repeat of a nationwide lockdown in the spring that battered the country's economy. This method is well-known and the formula is available so all experts can get the clear picture of how the vaccine works and of its benefits, namely that there are no adverse effects, except for maybe mild symptoms during the first few days.

According to the minister, he took the jab because he considered it his responsibility as he is in charge of the production of coronavirus vaccines.

Indian Woman Tortured in 'Toilet Jail' for Over a Year by Husband
The accused has been arrested and an investigation is underway, according to Surender Dahiya, incharge of Sanoli police station. Speaking to ANI, Gupta said that she acted upon information and rescued the woman on Wednesday.

President Vladimir Putin announced on Wednesday that Russian Federation has registered its second domestic Covid-19 vaccine, with a third already on the way.

A fourth vaccine being developed by CanSino Biologics was approved for use by the Chinese military in June.

The Philippines is also evaluating COVID-19 vaccines of Russia's Gamaleya Research Institute and Johnson & Johnson's Janssen for late-stage trials and is talking to US drugmaker Pfizer Inc and Moderna Inc as potential suppliers. That includes content that disputes the existence of COVID-19, discourages people from seeking medical treatment for the disease, and videos explicitly denying the efficacy of social distancing and self-isolation recommendations from health authorities that may lead people to act against those guidelines.

Health officials have so far declined to answer questions about EpiVacCorona's initial trial results or the approval process, saying that they were reviewing the vaccine for safety and quality.

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.